USA flag logo/image

An Official Website of the United States Government

QUALITY CONTROL TOOL FOR NEWBORN SCREENING BLOOD SAMPLES

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
60668
Program Year/Program:
2007 / SBIR
Agency Tracking Number:
HD037789
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
WESTERN RESEARCH COMPANY, INC.
3275 W INA RD, STE 215 TUCSON, AZ -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2007
Title: QUALITY CONTROL TOOL FOR NEWBORN SCREENING BLOOD SAMPLES
Agency: HHS
Contract: 2R44HD037789-04
Award Amount: $539,545.00
 

Abstract:

DESCRIPTION (provided by applicant): Essentially all newborns in the United States (about 4 million per year) and at least 30 other countries have blood samples obtained on filter paper cards for the purpose of screening for a number of metabolic and genet ic diseases. To prevent morbidity, such as brain damage, from metabolic diseases such as phenylketonuria or congenital hypothyroidism, it is critical that the screening results be obtained in a timely fashion. A persistent and well-documented problem for t he newborn screening programs has been the arrival of inadequate blood card samples at the testing laboratories. These result in expensive recall testing and introduce a dangerous delay in the diagnosis of disease. This project will develop an imaging base d system for the evaluation of blood cards to determine if they are adequate. Use of such a system at a birthing center will allow for the immediate correction of the problem, saving health care dollars and preventing any unnecessary delay in the diagnosis of important metabolic diseases. This project will result the development of a simple and economically advantageous computer based system for point of care use to determine if newborn screening blood sample cards are adequate for testing. This will allow for the immediate correction of inadequate cards prior to being sent to the lab for testing and while the newborn is still at the birthing center. The goal is to reduce dangerous delays in testing that can lead to avoidable morbidity and mortality associat ed with late diagnosis.

Principal Investigator:

Brian L. Craine
5203254505
BLCRAINE@WRC-INC.COM

Business Contact:

Eric Craine
5203254505
ERCRAINE@WRC-INC.COM
Small Business Information at Submission:

WESTERN RESEARCH COMPANY, INC.
WESTERN RESEARCH COMPANY, INC. 3275 W INA RD, STE 215 TUCSON, AZ 85741

EIN/Tax ID: 860608471
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No